melatonin has been researched along with Animal Mammary Carcinoma in 15 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study, the effect of long-term administration of peroral antidiabetic metformin and pineal hormone melatonin on liver antioxidant and aerobic status in female Sprague-Dawley rats carrying mammary tumors induced by N-methyl-N-nitrosourea was evaluated." | 5.48 | Liver antioxidant and aerobic status improves after metformin and melatonin administration in a rat model of high-fat diet and mammary carcinogenesis. ( Bojková, B; Kurhaluk, N; Winklewski, PJ, 2018) |
| "Melatonin has shown antitumor effects on cancer mammary cells; nevertheless, its effects have been poorly evaluated on canine mammary cancer stem-like cells." | 1.51 | Melatonin decreases in vitro viability and migration of spheres derived from CF41.Mg canine mammary carcinoma cells. ( Arias, JI; Guzmán, S; Serrano, C; Torres, CG, 2019) |
| " In the present study, the effect of long-term administration of peroral antidiabetic metformin and pineal hormone melatonin on liver antioxidant and aerobic status in female Sprague-Dawley rats carrying mammary tumors induced by N-methyl-N-nitrosourea was evaluated." | 1.48 | Liver antioxidant and aerobic status improves after metformin and melatonin administration in a rat model of high-fat diet and mammary carcinogenesis. ( Bojková, B; Kurhaluk, N; Winklewski, PJ, 2018) |
| "Melatonin has oncostatic actions and IL-25 is active in inflammatory processes that induce apoptosis in tumor cells AIM: The aim of this study was to evaluate melatonin and IL-25 in metastatic (CF-41) and non-metastatic (CMT-U229) canine mammary tumor cells cultured as monolayers and tridimensional structures." | 1.46 | Melatonin and IL-25 modulate apoptosis and angiogenesis mediators in metastatic (CF-41) and non-metastatic (CMT-U229) canine mammary tumour cells. ( Borin, TF; Gelaleti, GB; Hellmén, E; Maschio-Signorini, LB; Moschetta, MG; Viloria-Petit, AM; Zuccari, DAPC, 2017) |
| "The treatment with melatonin alone (2 mg/L in drinking water during the night time) or combined treatment with metformin (0." | 1.36 | Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo. ( Anikin, IV; Anisimov, VN; Egormin, PA; Karkach, AS; Piskunova, TS; Popovich, IG; Romanyukha, AA; Tyndyk, ML; Yurova, MN; Zabezhinski, MA, 2010) |
| "Isoproterenol (10(-6) M) was applied for 20 min after 2." | 1.32 | Long term inhibition by estradiol or progesterone of melatonin secretion after administration of a mammary carcinogen, the dimethyl benz(a)anthracene, in Sprague-Dawley female rat; inhibitory effect of Melatonin on mammary carcinogenesis. ( De Jonage-Canonico, MB; Kerdelhué, B; Lenoir, V; Martin, A; Scholler, R, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Serrano, C | 1 |
| Guzmán, S | 1 |
| Arias, JI | 1 |
| Torres, CG | 1 |
| Wu, D | 1 |
| Fan, Y | 1 |
| Liu, S | 1 |
| Woollam, MD | 1 |
| Sun, X | 1 |
| Murao, E | 1 |
| Zha, R | 1 |
| Prakash, R | 1 |
| Park, C | 1 |
| Siegel, AP | 1 |
| Liu, J | 1 |
| Agarwal, M | 1 |
| Li, BY | 1 |
| Yokota, H | 1 |
| Gelaleti, GB | 2 |
| Borin, TF | 1 |
| Maschio-Signorini, LB | 1 |
| Moschetta, MG | 2 |
| Hellmén, E | 1 |
| Viloria-Petit, AM | 1 |
| Zuccari, DAPC | 1 |
| Baxter, B | 1 |
| Kurhaluk, N | 1 |
| Bojková, B | 2 |
| Winklewski, PJ | 1 |
| Lopes, JR | 1 |
| Maschio, LB | 1 |
| Jardim-Perassi, BV | 1 |
| Ferreira, LC | 1 |
| Martins, GR | 1 |
| De Campos Zuccari, DA | 1 |
| Kubatka, P | 1 |
| Kassayová, M | 1 |
| Orendáš, P | 1 |
| Kajo, K | 1 |
| Výbohová, D | 1 |
| Kružliak, P | 1 |
| Adamicová, K | 1 |
| Péč, M | 1 |
| Stollárová, N | 1 |
| Adamkov, M | 1 |
| Moselhy, SS | 1 |
| Al mslmani, MA | 1 |
| Anisimov, VN | 1 |
| Egormin, PA | 1 |
| Piskunova, TS | 1 |
| Popovich, IG | 1 |
| Tyndyk, ML | 1 |
| Yurova, MN | 1 |
| Zabezhinski, MA | 1 |
| Anikin, IV | 1 |
| Karkach, AS | 1 |
| Romanyukha, AA | 1 |
| Umit, UM | 1 |
| Berna, T | 1 |
| Handan, K | 1 |
| Ipek, E | 1 |
| Berrak, Y | 1 |
| Can, E | 1 |
| Bahadir, GM | 1 |
| De Jonage-Canonico, MB | 2 |
| Lenoir, V | 2 |
| Martin, A | 2 |
| Scholler, R | 2 |
| Kerdelhué, B | 2 |
| Perrin, MH | 1 |
| Cos, S | 1 |
| González, A | 1 |
| Güezmes, A | 1 |
| Mediavilla, MD | 1 |
| Martínez-Campa, C | 1 |
| Alonso-González, C | 1 |
| Sánchez-Barceló, EJ | 1 |
| Bullough, JD | 1 |
| Rea, MS | 1 |
| Figueiro, MG | 1 |
| Kothari, A | 1 |
| Borges, A | 1 |
| Kothari, L | 1 |
1 review available for melatonin and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Of mice and women: light as a circadian stimulus in breast cancer research.
Topics: Animals; Breast Neoplasms; Circadian Rhythm; Disease Models, Animal; Female; Humans; Light; Light Si | 2006 |
14 other studies available for melatonin and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Melatonin decreases in vitro viability and migration of spheres derived from CF41.Mg canine mammary carcinoma cells.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Survival; Dog Diseases; Dogs; Female; Mammary Neoplas | 2019 |
Loading-induced antitumor capability of murine and human urine.
Topics: Adolescent; Adult; Animals; Cell Line, Tumor; Disease Models, Animal; Dopamine; Exercise; Female; Hu | 2020 |
Melatonin and IL-25 modulate apoptosis and angiogenesis mediators in metastatic (CF-41) and non-metastatic (CMT-U229) canine mammary tumour cells.
Topics: Animals; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Dog Diseases; Dogs; Female; Fluoresc | 2017 |
Is melatonin of value in cancer treatment? Experience with a case of feline mammary carcinoma.
Topics: Animals; Carcinoma; Cat Diseases; Cats; Female; Mammary Neoplasms, Animal; Melatonin; Treatment Outc | 2017 |
Liver antioxidant and aerobic status improves after metformin and melatonin administration in a rat model of high-fat diet and mammary carcinogenesis.
Topics: Aerobiosis; Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Carcinogenesis | 2018 |
Evaluation of melatonin treatment in primary culture of canine mammary tumors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dog Diseases; Dogs; Dr | 2015 |
Combination of Pitavastatin and melatonin shows partial antineoplastic effects in a rat breast carcinoma model.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Fe | 2014 |
Chemopreventive effect of lycopene alone or with melatonin against the genesis of oxidative stress and mammary tumors induced by 7,12 dimethyl(a)benzanthracene in sprague dawely female rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antioxidants; Carcinogens; Carotenoids; Female; Lycopene; | 2008 |
Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo.
Topics: Adenocarcinoma; Age Factors; Animals; Female; Longevity; Male; Mammary Neoplasms, Animal; Melatonin; | 2010 |
Role of melatonin and luzindole in rat mammary cancer.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Disease Models, Animal; DNA Fragmentation; Estradiol; Female; | 2012 |
Long term inhibition by estradiol or progesterone of melatonin secretion after administration of a mammary carcinogen, the dimethyl benz(a)anthracene, in Sprague-Dawley female rat; inhibitory effect of Melatonin on mammary carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adrenergic beta-Agonists; Animals; Antioxidants; Carcinogens; Carc | 2003 |
Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague-Dawley rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Antioxidants; Carcinogens; Cell Transform | 2005 |
Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antioxidants; Aromatase; Aromatase Inhibitors; Carcinogen | 2006 |
Chemoprevention by melatonin and combined melatonin-tamoxifen therapy of second generation nitroso-methylurea-induced mammary tumours in rats.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemother | 1995 |